Corvus Pharmaceuticals (CRVS) Other Non-Current Liabilities (2015 - 2025)
Corvus Pharmaceuticals (CRVS) posted quarterly Other Non-Current Liabilities of $3.8 million for Q1 2025, down 86.86% quarter-over-quarter from $28.9 million in Q4 2024.
Corvus Pharmaceuticals (CRVS) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends
Corvus Pharmaceuticals' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $3.8 million for Q1 2025.
- In Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $3.8 million; the TTM figure through Mar 2025 stood at $3.8 million (changed N/A YoY), while the FY2024 annual figure was $28.9 million, changed N/A from the prior year.
- Other Non-Current Liabilities for Q1 2025 stood at $3.8 million, down from $28.9 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $40.0 million in Q3 2024, with the low at $3.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.25 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 28.91 Mn |
| Sep 30, 2024 | 39.96 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Dec 31, 2018 | 869,000.00 |
| Sep 30, 2018 | 627,000.00 |
| Jun 30, 2018 | 741,000.00 |
| Mar 31, 2018 | 857,000.00 |
| Dec 31, 2017 | 971,000.00 |
| Sep 30, 2017 | 1.08 Mn |
| Jun 30, 2017 | 1.19 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 1.41 Mn |
| Sep 30, 2016 | 1.26 Mn |
| Jun 30, 2016 | 1.35 Mn |
| Mar 31, 2016 | 1.29 Mn |
| Dec 31, 2015 | 710,000.00 |